At the news
? NEUTRALIMPACT 3/10 DEFA14A filed Apr 17, 2026 at 16:14 ET
Exelixis, Inc. filed a supplement to its definitive proxy statement to clarify the voting standard for Proposal No. 3, which relates to the approval of the Amended 2017 Plan. The clarification specifies that a majority of shares present or represented by proxy is required for approval, with abstentions counting as votes against and broker non-votes having no effect.
- The filing is a supplement to the DEF 14A proxy statement for the 2026 Annual Meeting of Stockholders.
- The sole purpose is to correct the voting standard description for Proposal No. 3 (Amended 2017 Plan).
- The required vote is a majority of shares present or represented by proxy; abstentions count as votes against, broker non-votes have no effect.
- No other changes are made to the original proxy statement.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access